financetom
Business
financetom
/
Business
/
Independent committee says Praxis' tremor drug trial unlikely to meet main goal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Independent committee says Praxis' tremor drug trial unlikely to meet main goal
Feb 28, 2025 5:29 AM

Feb 28 (Reuters) - Praxis Precision Medicines ( PRAX )

said on Friday an independent committee had recommended its

tremor drug trial be stopped for futility, as it was unlikely to

meet its main goal.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MarketWise Chair, Chief Executive F. Porter Stansberry Resigns; Interim Replacements Named -- Shares Drop
MarketWise Chair, Chief Executive F. Porter Stansberry Resigns; Interim Replacements Named -- Shares Drop
Aug 12, 2024
02:58 PM EDT, 08/12/2024 (MT Newswires) -- MarketWise ( MKTW ) said Monday F. Porter Stansberry resigned as chair and chief executive on Friday. David Eifrig has been appointed as interim CEO, while Matthew Turner has been named the acting chairman of the board, MarketWise ( MKTW ) said in a regulatory filing with the Securities and Exchange Commission. MarketWise...
Mosaic Benefits From High Phosphate Prices; H2 Performance Crucial Amid Operational Improvements, RBC Says
Mosaic Benefits From High Phosphate Prices; H2 Performance Crucial Amid Operational Improvements, RBC Says
Aug 12, 2024
03:06 PM EDT, 08/12/2024 (MT Newswires) -- Mosaic (MOS) is benefiting from the elevated phosphate prices due to a tight supply resulting from restrictions in China, production issues in Saudi Arabia and North America, and controlled production increases in Morocco, RBC Capital Markets said in a note emailed Monday. Phosphate prices are expected to remain higher than historical levels but...
Nvidia's Data Center Business Seen Driving Second-Quarter Upside, UBS Says
Nvidia's Data Center Business Seen Driving Second-Quarter Upside, UBS Says
Aug 12, 2024
02:58 PM EDT, 08/12/2024 (MT Newswires) -- Nvidia ( NVDA ) is on track to report stronger-than-expected fiscal second-quarter results later this month amid strength in its data center business, UBS said in a note emailed Monday. The brokerage forecasts data center revenue as high as $26.3 billion for the July quarter, well above the consensus view of $25 billion....
RBC's former CFO sues Canadian bank for wrongful termination, citing gender stereotyping
RBC's former CFO sues Canadian bank for wrongful termination, citing gender stereotyping
Aug 12, 2024
TORONTO, Aug 12 (Reuters) - Royal Bank of Canada's ( RY ) former CFO Nadine Ahn has filed a wrongful-termination lawsuit against the bank, and alleged that gender-based stereotyping was at play in her dismissal. In April, RBC, Canada's biggest bank, said it had terminated Ahn after its investigation found she was in an undisclosed close personal relationship with another...
Copyright 2023-2026 - www.financetom.com All Rights Reserved